Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.2000
-0.0009 (-0.45%)
Apr 17, 2025, 4:00 PM EDT - Market closed

Carisma Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-60.48-86.88-61.23-40.78-28.35
Depreciation & Amortization
3.352.841.890.680.45
Other Amortization
-1.282.54--
Loss (Gain) From Sale of Assets
-0.030.16---
Asset Writedown & Restructuring Costs
0.36----
Loss (Gain) From Sale of Investments
--1.11---
Stock-Based Compensation
3.652.320.280.480.16
Other Operating Activities
5.185.656.210.831.18
Change in Accounts Payable
-1.852.19-0.47-0.971.28
Change in Unearned Revenue
-1.43-1.0547.46--
Change in Other Net Operating Assets
-8.67-6.58-1.792.44-1.74
Operating Cash Flow
-59.92-81.18-5.12-37.33-27.01
Capital Expenditures
-0.12-1.13-4.66-1.87-0.44
Investment in Securities
-73.54-27.9--
Investing Cash Flow
-0.1272.41-32.56-1.87-0.44
Long-Term Debt Issued
0.691.1836.63--
Long-Term Debt Repaid
-2.74-2.37-0.96--
Net Debt Issued (Repaid)
-2.05-1.1935.66--
Issuance of Common Stock
2.431.420.11-0.02
Other Financing Activities
-31.94-2.45-0.37-
Financing Cash Flow
0.3462.1833.3215.9672.26
Net Cash Flow
-59.753.41-4.36-23.2444.81
Free Cash Flow
-60.04-82.31-9.78-39.2-27.45
Free Cash Flow Margin
-305.83%-551.71%-99.41%--
Free Cash Flow Per Share
-1.45-2.46-4.59-36.16-25.82
Cash Interest Paid
0.190.350.1--
Levered Free Cash Flow
-33.4-50.63-30.1-24.24-
Unlevered Free Cash Flow
-33.4-51.91-30.68-24.24-
Change in Net Working Capital
2.670.48-6.92-1.97-
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q